Our integrated ecosystem approach will deliver seamless infrastructure across investor relations, market intelligence, credit facilities, and media—creating unprecedented value for OTC-listed companies and their stakeholders.
Enterprise SaaS platform providing best-in-class investor relations tools, engagement management, and shareholder communications for OTC companies.
- Full Stack IR Offering
- Automated SMS and Email messaging
- Shareholder analytics
Real-time prediction markets aggregating crowd-sourced intelligence on OTC company performance, milestones, and market sentiment.
- Event-based trading
- Sentiment indicators
- Price discovery tools
Credit and lending infrastructure connecting OTC companies with institutional capital providers for growth financing and working capital.
- Revenue-based financing
- Asset-backed lending
- Trade credit facilities
Dedicated news and media platform delivering pre-market coverage of material events, corporate actions, and market-moving developments in the OTC.
- Pre-market news of the day
- Earnings coverage
- Market commentary
OTCfi ACCESS represents our first commercial launch and cornerstone revenue driver. With 12,000+ companies actively trading on OTC Markets and minimal existing infrastructure competition, we project significant market penetration by 2027.
The OTC marketplace remains dramatically underserved by modern SaaS infrastructure. Legacy providers offer fragmented, outdated solutions while most companies operate without professional IR platforms entirely.
Our target addressable market includes OTCQX, OTCQB, OTCID, and Pink tier companies seeking to professionalize their investor communications and enhance market credibility.
Achieving 10% market penetration (1,200 companies) at an average subscription rate of $3,000 per month generates $43.3M in annual recurring revenue.
This conservative projection assumes tier-based pricing from $2,500/month (Bronze tier) to $25,000/month (Gold), with enterprise contracts for high-volume issuers.
Complete ACCESS beta testing and onboard initial 20 pilot customers. Refine pricing tiers and refine product-market fit.
Scale to 50 active subscriptions through strategic partnerships such as OTC Markets Group, transfer agents, and market makers.
Cross-sell additional ecosystem products. Expand to 300 customers with enhanced automation features and integration capabilities.
Achieve 1,200+ customers representing 10% market share. Establish ACCESS as the industry-standard IR platform for OTC companies.
Actively traded OTC-listed companies
Annual recurring revenue at target penetration
Expected avg rate across all pricing tiers
Ecosystem platforms creating network effects
No integrated SaaS platform currently serves the OTC market comprehensively. We're building infrastructure where none exists, not competing for replacement cycles.
Our multi-product approach creates switching costs. Companies adopting ACCESS gain access to desirable integrated addons that become crucial to success.
As an OTC traded company ourselves, Metavesco shares a common goal of improving the OTC experience for investors and leveraging resources for issuers. Improving liquidity is good for everyone.
Each additional subscriber strengthens the entire ecosystem. More companies using ACCESS means better data for Pulse predictions, enhanced credit profiles for Nexus, and richer content for Squawk.
"The OTC markets have operated on outdated infrastructure for decades. While Nasdaq and NYSE-listed companies enjoy sophisticated IR platforms, data terminals, robust capital formation, and media coverage, the 12,000+ companies that trade on the OTC have been systematically underserved."
"We're changing that. The OTCfi Ecosystem represents a fundamental reimagining of how micro-cap and small-cap companies access capital, communicate with investors, and build institutional credibility. This isn't incremental improvement—it's necessary infrastructure that will benefit every OTC traded issuer and the entire OTC market structure."
"We believe the next decade will see a dramatic upgrade of the OTC marketplace. Metavesco is positioned to capture that transformation and deliver substantial returns to early investors who recognize this opportunity."
Ryan Schadel - President and CEO
Metavesco, Inc.
12,000+ OTC-listed companies represent a $400M+ annual opportunity at full market penetration. Current infrastructure penetration leaves substantial white space for growth.
SaaS subscriptions should generate predictable, high-margin revenue with strong unit economics. Substantial upsell opportunities with an ever growing suite of product offerings.
Each ecosystem component reinforces the others. ACCESS attracts traders to the OTC which become Pulse users; Pulse data improves Nexus underwriting; all generate Squawk content—creating compounding value.
Cloud-native architecture enables rapid scaling without proportional cost increases. Incremental customers add revenue with minimal marginal expense, driving operating leverage as we grow.
Comprehensive documentation, financial statements, and corporate governance materials are available on otcmarkets.com.
Real-time stock data, trading volumes, and market statistics are accessible through most major financial data providers.
Contact: info@metavesco.com
Metavesco, Inc.
410 Peachtree Parkway
Suite 2425
Cumming, GA 30041
Phone: 678-341-5898
Follow Us:
X: @metavesco | @otcfi
Ryan Schadel, President and CEO: @cryanschadel
© 2024 Metavesco, Inc. All rights reserved. MVCO is traded on the OTC Markets under ticker symbol MVCO.
Metavesco, Inc. (Ticker: MVCO) is architecting the OTCfi Ecosystem—a comprehensive multi-platform infrastructure designed to modernize capital formation, data transparency, and investor engagement across the entire OTC marketplace.